Related Experiment Video
Updated: Jan 12, 2026

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
From Nature to Neuroscience: Exploring Carvacrol's Therapeutic Potential in Brain Health
Ahsas Goyal1, Anshika Kumari1, Aanchal Verma1
1Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
None:
Carvacrol is a major active compound present in the essential oils of various aromatic plants. Research strongly indicates that carvacrol holds considerable promise for use in the development of new pharmaceutical drugs and dietary supplements. Due to its broad spectrum of bioactive properties, carvacrol shows potential therapeutic applications for several complex and challenging brain-related disorders. Its actions are multifaceted; it mitigates neuroinflammation and exerts antioxidant properties as well as other neuroprotective effects that shield neural structures from degeneration. Additionally, carvacrol influences important neural systems, including the cholinergic and dopaminergic pathways, helping to regulate neurotransmitter levels and activity in ways that could mitigate neurological symptoms. Furthermore, its anti-apoptotic effects suggest that it can help prevent programmed cell death, a common factor in neurodegenerative diseases. Collectively, these biological properties make carvacrol an attractive option for use as an adjunctive or supportive therapy in managing a range of brain illnesses, including epilepsy, anxiety, depression, stroke, Parkinson's disease, and Alzheimer's disease. This study presents an extensive review of in vitro as well as in vivo research studies on carvacrol's protective effects across different brain disorders. By examining these studies, this review offers a comprehensive and up-to-date assessment of the biological activities and molecular mechanisms of carvacrol, emphasizing its potential role in therapeutic strategies aimed at supporting brain health and treating complex neurological conditions.
Related Concept Videos
Alzheimer's Disease: Treatment
Drugs Affecting Neurotransmitter Synthesis
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Drugs Affecting Neurotransmitter Release or Uptake
Neurochemical Transmission: Sites of Drug Action

